Clinical Trials Logo
  1. Home
  2. Blood Transfusion Complication
  3. NCT05314582

Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

Hematuria Clinical Trial

Official title:
Investigation of the Effects of Anticoagulant/Antiaggregant Use on Postoperative Bleeding Risk in Patients Operated for Bladder Tumor and Benign Prostatic Hyperplasia

Clinical Trial Summary

Patients who were using anticoagulant or antiaggregant medications for any reason and underwent transurethral resection of bladder tumor (TUR-BT) or transurethral resection of the prostate (TURP) or open prostatectomy (OP) due to BPH will be compared with those who were not using anticoagulant or antiplatelet medication. The rates of postoperative clot retention, presence of hematuria, reoperation due to hematuria, blood transfusion and re-admissions due to hematuria in the first postoperative month will be compared.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05314582
Study type Observational [Patient Registry]
Source Bezmialem Vakif University
Contact
Status Completed
Phase
Start date March 10, 2022
Completion date January 10, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Active, not recruiting NCT03988309 - STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA N/A
Completed NCT05011253 - Electronic Triggers: Microhematuria Trigger N/A
Completed NCT02276924 - Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors N/A
Active, not recruiting NCT04943380 - Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Recruiting NCT05646485 - Bladder Cancer Screening Trial N/A
Recruiting NCT06026189 - Safely Reduce Cystoscopic Evaluations for Hematuria Patients N/A
Active, not recruiting NCT03122964 - Multi Institutional Study in Patient Presenting With Hematuria
Completed NCT02381912 - Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer N/A
Completed NCT01812928 - Diclofenac Suppository to Control Pain During Flexible Cystoscopy Phase 2
Active, not recruiting NCT01563796 - Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer N/A
Terminated NCT00600691 - The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy Phase 2
Completed NCT00231322 - Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique N/A
Recruiting NCT05620784 - Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP Phase 3
Completed NCT04555343 - Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention Phase 1/Phase 2
Completed NCT04317261 - Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria N/A
Completed NCT03210038 - Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia? N/A
Not yet recruiting NCT06427993 - Urine DNA Methylation Detection for Hematuria Evaluation
Recruiting NCT03965975 - Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device N/A
Not yet recruiting NCT05893316 - UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study